Uninsured individuals or those with high-deductible health plans may order the discounted drug through a startup called Blink Health, which offers savings on prescription drugs through a free app and website.
Eli Lilly produces several insulin products, including Humalog, which has jumped in cost from $21 a vial in 1996 to $255 in 2016.
According to the Chicago Tribune, the program represents part of a growing effort among drug companies to combat public scrutiny of high drug prices.
“The healthcare system is incredibly complex, and we hope this program is a first step that will drive more thinking and innovative solutions for people with diabetes,” Enrique Conterno, president of Lilly Diabetes, said in a news release. “A more extensive solution will require leadership and cooperation across many stakeholders, including manufacturers, pharmacy benefit managers, insurers and patients.”
More articles on supply chain:
5 ways robots could change warehouse design
UPMC Health Plan expands collaboration with MedVantx to improve medication adherence
FDA new drug approvals for 2016 lowest in 6 years
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
